.
Method Development and Validation of Lorlatinib by RP-HPLC
浏览量 419 时间 2024-08-20 09:04:33

Santhosh Illendula1*, Dr. Shailesh Sharma2

1Research scholar, Department of Pharmacy, Shyam university, Dausa-303511, Rajasthan, India.

2Principal and Professor, Department of Pharmacy, Shyam university, Dausa-303511, Rajasthan, India.


* Address    for  Correspondence:

SANTHOSH ILLENDULA,

Research Scholor, Shyam University, Duasa, Rajasthan

Tel: 07075325305

E-mail: santoshillendula@gmail.com


Abstract

A simple, Accurate, precise method was developed for the estimation of the Lorlatinib in API form and Marketed pharmaceutical dosage form by RP-HPLC. Chromatogram was run through Hypersil C18 (4.6mm×150mm, 5µm) Particle size Column and Mobile phase containing Methanol and Water taken in the ratio of 25: 75% v/v was pumped through column at a flow rate of 1.0 ml/min. Temperature was maintained at 38ºC. Optimized wavelength selected was 310 nm. Retention times of Lorlatinib were found to be 3.513 minutes respectively. The %RSD for the Repeatability and Intermediate Precision of the Lorlatinib were found to be within limits. %Recovery was obtained 98.96% and it  was found to be within the limits for Lorlatinib respectively. The LOD, LOQ values obtained from regression equations of Lorlatinib were 0.332µg/ml and 1.0078 µg/ml respectively. Regression equation of Lorlatinib was found to be y = 39948x + 16821 respectively. The Retention times was decreased and run time was decreased, so the method developed was simple and economical that can be adopted in regular Quality control test in Industries.


Keywords  Lorlatinib, RP-HPLC, Method Development, Validation, Accuracy

PDF Method Development and Validation of Lorlatinib by RP-HPLC.pdf